Cargando…
Eyes as the windows into cardiovascular disease in the era of big data
Cardiovascular disease (CVD) is a major cause of mortality and morbidity worldwide and imposes significant socioeconomic burdens, especially with late diagnoses. There is growing evidence of strong correlations between ocular images, which are information-dense, and CVD progression. The accelerating...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10361436/ https://www.ncbi.nlm.nih.gov/pubmed/37484607 http://dx.doi.org/10.4103/tjo.TJO-D-23-00018 |
_version_ | 1785076215801970688 |
---|---|
author | Chan, Yarn Kit Cheng, Ching-Yu Sabanayagam, Charumathi |
author_facet | Chan, Yarn Kit Cheng, Ching-Yu Sabanayagam, Charumathi |
author_sort | Chan, Yarn Kit |
collection | PubMed |
description | Cardiovascular disease (CVD) is a major cause of mortality and morbidity worldwide and imposes significant socioeconomic burdens, especially with late diagnoses. There is growing evidence of strong correlations between ocular images, which are information-dense, and CVD progression. The accelerating development of deep learning algorithms (DLAs) is a promising avenue for research into CVD biomarker discovery, early CVD diagnosis, and CVD prognostication. We review a selection of 17 recent DLAs on the less-explored realm of DL as applied to ocular images to produce CVD outcomes, potential challenges in their clinical deployment, and the path forward. The evidence for CVD manifestations in ocular images is well documented. Most of the reviewed DLAs analyze retinal fundus photographs to predict CV risk factors, in particular hypertension. DLAs can predict age, sex, smoking status, alcohol status, body mass index, mortality, myocardial infarction, stroke, chronic kidney disease, and hematological disease with significant accuracy. While the cardio-oculomics intersection is now burgeoning, very much remain to be explored. The increasing availability of big data, computational power, technological literacy, and acceptance all prime this subfield for rapid growth. We pinpoint the specific areas of improvement toward ubiquitous clinical deployment: increased generalizability, external validation, and universal benchmarking. DLAs capable of predicting CVD outcomes from ocular inputs are of great interest and promise to individualized precision medicine and efficiency in the provision of health care with yet undetermined real-world efficacy with impactful initial results. |
format | Online Article Text |
id | pubmed-10361436 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-103614362023-07-22 Eyes as the windows into cardiovascular disease in the era of big data Chan, Yarn Kit Cheng, Ching-Yu Sabanayagam, Charumathi Taiwan J Ophthalmol Review Article Cardiovascular disease (CVD) is a major cause of mortality and morbidity worldwide and imposes significant socioeconomic burdens, especially with late diagnoses. There is growing evidence of strong correlations between ocular images, which are information-dense, and CVD progression. The accelerating development of deep learning algorithms (DLAs) is a promising avenue for research into CVD biomarker discovery, early CVD diagnosis, and CVD prognostication. We review a selection of 17 recent DLAs on the less-explored realm of DL as applied to ocular images to produce CVD outcomes, potential challenges in their clinical deployment, and the path forward. The evidence for CVD manifestations in ocular images is well documented. Most of the reviewed DLAs analyze retinal fundus photographs to predict CV risk factors, in particular hypertension. DLAs can predict age, sex, smoking status, alcohol status, body mass index, mortality, myocardial infarction, stroke, chronic kidney disease, and hematological disease with significant accuracy. While the cardio-oculomics intersection is now burgeoning, very much remain to be explored. The increasing availability of big data, computational power, technological literacy, and acceptance all prime this subfield for rapid growth. We pinpoint the specific areas of improvement toward ubiquitous clinical deployment: increased generalizability, external validation, and universal benchmarking. DLAs capable of predicting CVD outcomes from ocular inputs are of great interest and promise to individualized precision medicine and efficiency in the provision of health care with yet undetermined real-world efficacy with impactful initial results. Wolters Kluwer - Medknow 2023-06-13 /pmc/articles/PMC10361436/ /pubmed/37484607 http://dx.doi.org/10.4103/tjo.TJO-D-23-00018 Text en Copyright: © 2023 Taiwan J Ophthalmol https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Review Article Chan, Yarn Kit Cheng, Ching-Yu Sabanayagam, Charumathi Eyes as the windows into cardiovascular disease in the era of big data |
title | Eyes as the windows into cardiovascular disease in the era of big data |
title_full | Eyes as the windows into cardiovascular disease in the era of big data |
title_fullStr | Eyes as the windows into cardiovascular disease in the era of big data |
title_full_unstemmed | Eyes as the windows into cardiovascular disease in the era of big data |
title_short | Eyes as the windows into cardiovascular disease in the era of big data |
title_sort | eyes as the windows into cardiovascular disease in the era of big data |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10361436/ https://www.ncbi.nlm.nih.gov/pubmed/37484607 http://dx.doi.org/10.4103/tjo.TJO-D-23-00018 |
work_keys_str_mv | AT chanyarnkit eyesasthewindowsintocardiovasculardiseaseintheeraofbigdata AT chengchingyu eyesasthewindowsintocardiovasculardiseaseintheeraofbigdata AT sabanayagamcharumathi eyesasthewindowsintocardiovasculardiseaseintheeraofbigdata |